Literature DB >> 11018579

Adherence to pharmacological interventions. Current trends and future directions. The Pharmacological Intervention Working Group.

S Ellis1, S Shumaker, W Sieber, C Rand.   

Abstract

The complexity of adherence to pharmacological interventions is frequently underestimated. Consequently, little research has been done to understand, improve, or evaluate the effects of adherence to drug protocols. While efforts to better measure and increase adherence require dedicated resources, improved adherence in existing clinical research can potentially cut costs in trial size and length. This paper outlines strategies to facilitate research on adherence to pharmacological interventions including: reporting of adherence data, changing how we conceptualize adherence to pharmaceuticals, understanding issues unique to older adults' pill-taking behavior, and creating standardized methodologies to measure adherence. Further, we describe some promising research areas that may lead to effective interventions: adherence "typologies" and modality matching. Control Clin Trials 2000;21:218S-225S

Mesh:

Year:  2000        PMID: 11018579     DOI: 10.1016/s0197-2456(00)00082-9

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  12 in total

1.  Race and medication adherence and glycemic control: findings from an operational health information exchange.

Authors:  Vivienne J Zhu; Wanzhu Tu; David G Marrero; Marc B Rosenman; J Marc Overhage
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

2.  Clinical outcomes and adherence to medications measured by claims data in patients with diabetes.

Authors:  Manel Pladevall; L Keoki Williams; Lisa Ann Potts; George Divine; Hugo Xi; Jennifer Elston Lafata
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

Review 3.  A meta-analysis of the association between adherence to drug therapy and mortality.

Authors:  Scot H Simpson; Dean T Eurich; Sumit R Majumdar; Rajdeep S Padwal; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson
Journal:  BMJ       Date:  2006-06-21

4.  Adherence and renal biopsy feasibility in the Renin Angiotensin-System Study (RASS) primary prevention diabetes trial.

Authors:  William N Robiner; Trudy D Strand; Michael Mauer
Journal:  Diabetes Res Clin Pract       Date:  2013-09-17       Impact factor: 5.602

5.  Desirability and feasibility of wireless electronic monitoring of medications in clinical trials.

Authors:  William N Robiner; Nancy Flaherty; Thyra A Fossum; Thomas E Nevins
Journal:  Transl Behav Med       Date:  2015-09       Impact factor: 3.046

Review 6.  Current issues in pediatric medication adherence.

Authors:  Doreen Matsui
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

7.  Predictors of adherence in the Women's Health Initiative Calcium and Vitamin D Trial.

Authors:  R Brunner; J Dunbar-Jacob; M S Leboff; I Granek; D Bowen; L G Snetselaar; S A Shumaker; J Ockene; M Rosal; J Wactawski-Wende; J Cauley; B Cochrane; L Tinker; R Jackson; C Y Wang; L Wu
Journal:  Behav Med       Date:  2009       Impact factor: 3.104

8.  An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures.

Authors:  Jacqueline A Pesa; Jill Van Den Bos; Travis Gray; Colleen Hartsig; Robert Brett McQueen; Joseph J Saseen; Kavita V Nair
Journal:  Patient Prefer Adherence       Date:  2012-01-18       Impact factor: 2.711

9.  Pharmacist counseling to cardiac patients in Israel prior to discharge from hospital contribute to increasing patient's medication adherence closing gaps and improving outcomes.

Authors:  Bishara Bisharat; Lubna Hafi; Orna Baron-Epel; Zaher Armaly; Abdalla Bowirrat
Journal:  J Transl Med       Date:  2012-03-01       Impact factor: 5.531

Review 10.  Enhancing adherence in trials promoting change in diet and physical activity in individuals with a diagnosis of colorectal adenoma; a systematic review of behavioural intervention approaches.

Authors:  Deborah McCahon; Amanda J Daley; Janet Jones; Richard Haslop; Arjun Shajpal; Aliki Taylor; Sue Wilson; George Dowswell
Journal:  BMC Cancer       Date:  2015-07-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.